XCL1 attracts activated T cells and NK cells, and its binding to XCR1 receptors may alleviate various inflammatory diseases. Enhancing XCL1-XCR1 signaling could improve treatments for severe infections and tumors, contributing to bactericidal activity and immune responses. The gene discussed is XCL1; the disease is infection.